Physician profile
Cassandra White
NPI 1316408826
$699.66
in general payments reported to CMS, 2019-2025
17 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $173 · 2024: $249 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.67 | 2023-2025 | Vraylar, Ubrelvy |
| Otsuka America Pharmaceutical, INC. | $117.21 | 2023-2025 | Rexulti |
| Dexcom, INC. | $81.21 | 2023-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $63.87 | 2023-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $34.87 | 2023-2025 | |
| Organon LLC | $30.46 | 2023-2024 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $28.82 | 2024 | Farxiga, Breztri |
| Astellas Pharma US INC | $24.79 | 2025 | Veozah |
| Eisai INC. | $22.01 | 2025 | |
| Hologic Sales and Service, LLC | $20.86 | 2025 | Thinprep 2000 Processor, Aptima |
| Boston Scientific Corporation | $17.68 | 2025 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $17.62 | 2024 | |
| Radius Health, INC. | $16.14 | 2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.86 | 2025 | |
| Pfizer INC. | $14.51 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.09 | 2024 | Vaxneuvance, Gardasil, Gardasil 9 |
| Exact Sciences Corporation | $13.99 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.